News & Perspective

Dec 11, 2012

Dec 11, 2012

HHS offers some forecasts on medical countermeasures

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

Nov 09, 2012

Nov 09, 2012

BioCryst may drop quest for US approval of peramivir

(CIDRAP News) – BioCryst Pharmaceuticals Inc. signaled yesterday it will probably give up on seeking a US license for the influenza drug peramivir, a move that would reduce the already limited options for severely ill flu patients in need of an intravenous antiviral drug.

Jun 15, 2012

Jun 15, 2012

WHO report sums up Northern Hemisphere flu season

(CIDRAP News) – The 2011-12 flu season in most temperate countries of the Northern Hemisphere started later than usual, except for North Africa, and was mild in many countries, the World Health Organization (WHO) said today in a wrap-up report.

May 11, 2012

May 11, 2012

Flu activity at low levels in US, worldwide

(CIDRAP News) – US influenza activity declined overall and in most regions last week, the Centers for Disease Control and Prevention (CDC) reported today, while Northern Hemisphere flu activity in general continued to fall.

Feb 03, 2012

Feb 03, 2012

Flu continues late-season Northern Hemisphere push

(CIDRAP News) – Flu activity in many Northern Hemisphere countries continued its late-season rise last week, with areas such as the United States, Canada, and Europe reporting steady increases.

Though flu activity overall is low, notable increases are occurring in North America, western Europe, and northern China, the World Health Organization (WHO) said today.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»